3,840
Participants
Start Date
May 13, 2022
Primary Completion Date
April 30, 2025
Study Completion Date
June 30, 2026
Multi-condition Pathway Intervention
See Experimental/Arm 1 description
University of California, San Francisco, San Francisco
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Society of Hospital Medicine
OTHER
University of California, San Francisco
OTHER